High-risk localized prostate cancer treated with neoadjuvant LHRH agonist/antagonist and enzalutamide plus the glucocorticoid receptor antagonist relacorilant versus placebo. This is an ASCO Meeting ...
Morning Overview on MSN
Study finds AI health chatbots do not improve self-diagnosis
A randomized trial led by researchers at the University of Oxford found that people who used AI chatbots to assess their ...
MedPage Today on MSN
New TYK2 inhibitors for psoriasis achieve high clearance rates in randomized trials
Three-fourths of patients have 70-75% improvement at 16 weeks with zasocitinib, envudeucit ...
Whole-blood transfusion has recently gained favor in the management of severe hemorrhage; however, data from large clinical trials evaluating its clinical effectiveness and safety are lacking. We ...
The European Randomized Study of Screening for Prostate Cancer (ERSPC) was initiated in 1993 to assess the effect of prostate-specific antigen (PSA) testing on prostate cancer mortality. Because ...
In what is believed to be the first randomized placebo-controlled trial of its kind, patients with a chronic total blockage ...
Providence Medical Technology’s latest randomized controlled trial is designed to once again challenge the standard of care ...
An open-label, multicenter, phase 1/2 study of peluntamig (PT217), an anti-DLL3/anti-CD47 bispecific antibody, in patients with DLL3-expressing cancers such as SCLC, LCNEC and EP-NEC (SKYBRIDGE study) ...
BACKGROUND: Medically tailored meals (MTM) have unanswered implementation questions. Providing MTM for a specific individual, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results